Stephen J. Schueler, M.D.

Inflammatory Breast Cancer Types

The type of breast cancer is determined by which type of cell in the breast becomes cancerous.

The most common types include:

Inflammatory Breast Cancer DCIS

Facts about ductal carcinoma in situ (DCIS):

  • Ductal carcinoma in situ (DCIS) refers to cancer of the milk ducts that is confined to the milk ducts and has not spread outside the ducts.
  • DCIS tends to spread along the milk ducts.
  • DCIS also can be multifocal: meaning that it can appear in more than one portion of the breast.
  • Overall, DCIS is a more treatable form of cancer than infiltrating (or invasive) ductal carcinoma.
  • When DCIS is small and localized to one area, treatment will usually involve simple lumpectomy.
  • Radiation therapy may be offered in some cases following lumpectomy.

Inflammatory Breast Cancer Ductal Carcinoma

Facts about infiltrating ductal carcinoma:

  • Infiltrating ductal carcinoma accounts for up to 80% of all breast cancers in women.
  • This is a form of ductal carcinoma that has spread beyond the milk ducts.
  • This form of breast cancer typically causes a hard well-defined lump in the breast.
  • Infiltrating ductal carcinomas will often spread to the lymph nodes under the arm.

Inflammatory Breast Cancer LCIS

Facts about lobular carcinoma in situ (LCIS):

  • Lobular carcinoma in situ, or LCIS, is not an actual cancer, but a marker for potential invasive breast cancer.
  • The finding of LCIS on a breast biopsy put the patient at a risk of 1% per year of developing cancer in either breast.
  • If a cancer develops from the LCIS, it is more commonly ductal carcinoma as opposed to lobular carcinoma.
  • Women with LCIS may not need to have the lesion removed. They will however require close physician follow-up that includes yearly physician exams and mammography to make sure their condition does not change. Monthly breast self examination is also recommended.

Inflammatory Breast Cancer Medullary Carcinoma

Facts about medullary carcinoma of the breast:

  • A rare subtype of ductal carcinoma, a form of breast cancer that arises from the milk ducts.
  • Medullary carcinomas tend to be large and make up only 5-7% of all cases.
  • Can occur at any age, but usually affects women between the age of 40 and 55.
  • More common in women with the BRCA1 gene mutation.
  • More common in Japan than the United States.

Inflammatory Breast Cancer Mucinous Carcinoma

Facts about mucinous carcinoma:

  • This accounts for less than 3% of all breast cancers.
  • This is often a slow growing tumor that can reach larger size.
  • The prognosis tends to be better than some other types of breast cancer.

Inflammatory Breast Cancer Paget's Disease

Facts about Paget's disease:

  • Paget's disease of the nipple occurs in less than 1% of all women with breast cancer.
  • Symptoms include a long history of a rash around the nipple that causes itching, burning, oozing, bleeding, or some combination.
  • There is usually a tumor located under the diseased nipple

Inflammatory Breast Cancer Tubular Carcinoma

Facts about tubular carcinoma:

  • This is an uncommon form of breast cancer.
  • Spread to the lymph nodes under the arm is uncommon and the prognosis for this form of breast cancer is typically better than with infiltrating ductal carcinomas

Continue to Inflammatory Breast Cancer Anatomy

Last Updated: Dec 2, 2010 References
Authors: Stephen J. Schueler, MD; John H. Beckett, MD; D. Scott Gettings, MD
Copyright DSHI Systems, Inc. Powered by: FreeMD - Your Virtual Doctor

PubMed Inflammatory Breast Cancer References
  1. Aiello EJ, Buist DS, White E, Seger D, Taplin SH. Rate of breast cancer diagnoses among postmenopausal women with self-reported breast symptoms. J Am Board Fam Pract. 2004 Nov-Dec;17(6):408-15. [15575032]
  2. Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1997 Oct 11; 350(9084): 1047-59. [10213546]
  3. Giordano SH. A review of the diagnosis and management of male breast cancer. Oncologist. 2005 Aug;10(7):471-9. [16079314]
FreeMD is provided for information purposes only and should not be used as a substitute for evaluation and treatment by a physician. Please review our terms of use.